WHO rules call for manufacturers to apply a continual danger administration approach for sterility test isolators, such as common threat assessments and the development of risk-primarily based Regulate procedures. The WHO's rules provide not merely for a regulatory framework but also to be a roadmap for most effective procedures waiting for link from Forum Profiles (6)